Inventor · disambiguated record
Charles L. Sentman
Also filed as: SENTMAN CHARLES · SENTMAN CHARLES L
39 granted patents·17 pending applications·672 citations·filing 2005–2024
98Inventor score
Top patents by PatentIndex Score
56 records- 0198US9822340B1T-cell receptor-deficient T cell compositionsDARTMOUTH COLLEGE·Filed 2016·Granted Nov 21, 2017·24 cites·21 claims
- 0298US8252914B2Chimeric NK receptor and methods for treating cancerZHANG TONG·Filed 2011·Granted Aug 28, 2012·125 cites·5 claims
- 0398US7994298B2Chimeric NK receptor and methods for treating cancerDARTMOUTH COLLEGE·Filed 2005·Granted Aug 9, 2011·159 cites·4 claims
- 0497US11834676B2T cell receptor-deficient T cell compositionsDARTMOUTH COLLEGE·Filed 2022·Granted Dec 5, 2023·5 cites·12 claims
- 0597US10689616B1T-cell receptor-deficient t cell compositionsDARTMOUTH COLLEGE·Filed 2017·Granted Jun 23, 2020·8 cites·13 claims
- 0697US9938497B2T cell receptor-deficient T cell compositionsDARTMOUTH COLLEGE·Filed 2015·Granted Apr 10, 2018·15 cites·22 claims
- 0797US9821011B1T-cell receptor-deficient T cell compositionsDARTMOUTH COLLEGE·Filed 2016·Granted Nov 21, 2017·23 cites·20 claims
- 0897US9181527B2T cell receptor-deficient T cell compositionsSENTMAN CHARLES L·Filed 2010·Granted Nov 10, 2015·128 cites·23 claims
- 0996US9663763B2T-cell receptor-deficient T cell compositionsDARTMOUTH COLLEGE·Filed 2016·Granted May 30, 2017·30 cites·15 claims
- 1096US9273283B2Method of producing T cell receptor-deficient T cells expressing a chimeric receptorSENTMAN CHARLES L·Filed 2012·Granted Mar 1, 2016·64 cites·30 claims
- 1195US10689618B2T cell receptor-deficient T cell compositionsDARTMOUTH COLLEGE·Filed 2018·Granted Jun 23, 2020·4 cites·24 claims
- 1295US9957480B2T cell receptor-deficient T cell compositionsDARTMOUTH COLLEGE·Filed 2015·Granted May 1, 2018·11 cites·15 claims
- 1395US9833476B2NKP30 receptor targeted therapeuticsZHANG TONG·Filed 2012·Granted Dec 5, 2017·28 cites·15 claims
- 1494US11034766B2Anti-B7-H6 antibody, fusion proteins, and methods of using the sameDARTMOUTH COLLEGE·Filed 2017·Granted Jun 15, 2021·7 cites·20 claims
- 1594US2025129335A1T cell receptor-deficient t cell compositionsDARTMOUTH COLLEGE·Filed 2024·Application pending·0 cites
- 1694US2025230409A1T cell receptor-deficient t cell compositionsDARTMOUTH COLLEGE·Filed 2024·Application pending·0 cites
- 1793US12031156B2T cell receptor-deficient T cell compositionsDARTMOUTH COLLEGE·Filed 2020·Granted Jul 9, 2024·2 cites·19 claims
- 1893US2025002852A1T cell receptor-deficient t cell compositionsDARTMOUTH COLLEGE·Filed 2024·Application pending·0 cites
- 1992US11136549B2T-cell receptor-deficient T cell compositionsDARTMOUTH COLLEGE·Filed 2017·Granted Oct 5, 2021·4 cites·20 claims
- 2092US10689619B2T cell receptor-deficient T cell compositionsDARTMOUTH COLLEGE·Filed 2018·Granted Jun 23, 2020·2 cites·19 claims
- 2192US9790278B2Anti-B7-H6 antibody, fusion proteins, and methods of using the sameDARTMOUTH COLLEGE·Filed 2013·Granted Oct 17, 2017·14 cites·17 claims
- 2291US12146158B2T cell receptor-deficient T cell compositionsDARTMOUTH COLLEGE·Filed 2023·Granted Nov 19, 2024·0 cites·3 claims
- 2391US10682378B2NKP30 receptor targeted therapeuticsDARTMOUTH COLLEGE·Filed 2017·Granted Jun 16, 2020·3 cites·14 claims
- 2489US2024150427A1Methods for treating cancer using t cells which express a chimeric nk receptorDARTMOUTH COLLEGE·Filed 2023·Application pending·0 cites
- 2587US11034767B2High affinity B7-H6 antibodies and antibody fragmentsDARTMOUTH COLLEGE·Filed 2017·Granted Jun 15, 2021·8 cites·20 claims
- 2687US10744157B2Anti-MICA antigen binding fragments, fusion molecules, cells which express and methods of usingDARTMOUTH COLLEGE·Filed 2016·Granted Aug 18, 2020·4 cites·15 claims
- 2786US2025002584A1Anti-b7-h6 antibody, fusion proteins, and methods of using the sameDARTMOUTH COLLEGE·Filed 2024·Application pending·0 cites
- 2884US12384827B2Chimeric NK receptor and methods for treating cancerDARTMOUTH COLLEGE·Filed 2022·Granted Aug 12, 2025·0 cites·16 claims
- 2984US11858976B2Nucleic acid constructs encoding chimeric NK receptor, cells containing, and therapeutic use thereofDARTMOUTH COLLEGE·Filed 2022·Granted Jan 2, 2024·0 cites·22 claims
- 3082US11857571B2Anti-mica antigen binding fragments, fusion molecules, cells which express and methods of usingDARTMOUTH COLLEGE·Filed 2020·Granted Jan 2, 2024·1 cites·20 claims
- 3181US11365391B2Chimeric antigen receptor anti-inflammatory cells and methods of useDARTMOUTH COLLEGE·Filed 2016·Granted Jun 21, 2022·3 cites·22 claims
- 3279US11339199B2Chimeric NK receptor and methods for treating cancerDARTMOUTH COLLEGE·Filed 2019·Granted May 24, 2022·0 cites·19 claims
- 3379US11208454B2Chimeric NK receptor and methods for treating cancerDARTMOUTH COLLEGE·Filed 2019·Granted Dec 28, 2021·0 cites·17 claims
- 3477US12492375B2T-cell receptor-deficient T cell compositionsDARTMOUTH COLLEGE·Filed 2020·Granted Dec 9, 2025·0 cites·11 claims
- 3577US12291723B2T-cell receptor-deficient T cell compositionsDARTMOUTH COLLEGE·Filed 2020·Granted May 6, 2025·0 cites·5 claims
- 3676US12168780B2T cell receptor-deficient t cell compositionsDARTMOUTH COLLEGE·Filed 2020·Granted Dec 17, 2024·0 cites·5 claims
- 3776US10689617B1T-cell receptor-deficient T cell compositionsDARTMOUTH COLLEGE·Filed 2017·Granted Jun 23, 2020·0 cites·21 claims
- 3875US12065492B2Anti-B7-H6 antibody, fusion proteins, and methods of using the sameDARTMOUTH COLLEGE·Filed 2021·Granted Aug 20, 2024·0 cites·11 claims
- 3974US2025059281A1High affinity b7-h6 antibodies and antibody fragmentsDARTMOUTH COLLEGE·Filed 2024·Application pending·0 cites
- 4072US11872248B2Nucleic acids encoding chimeric receptor comprising NKP30 receptor and CD28 and CD3 zeta domains and human T cell containingDARTMOUTH COLLEGE·Filed 2020·Granted Jan 16, 2024·0 cites·19 claims
- 4170US2009202501A1Chimeric NK receptor and methods for treating cancerZHANG TONG·Filed 2009·Application pending·0 cites
- 4269US2023365650A1Chimeric antigen receptor, regulatory cells and methods of useDARTMOUTH COLLEGE·Filed 2023·Application pending·0 cites
- 4368US2025034217A1Nucleic acid constructs for co-expression of chimeric antigen receptor and transcription factor, cells containing and therapeutic use thereofDARTMOUTH COLLEGE·Filed 2024·Application pending·0 cites
- 4467US11952425B2High affinity B7-H6 antibodies and antibody fragmentsDARTMOUTH COLLEGE·Filed 2021·Granted Apr 9, 2024·0 cites·21 claims
- 4562US2011104121A1Female Reproductive Tract and Anal ProphylaxesWIRA CHARLES R·Filed 2009·Application pending·0 cites
- 4662US2024189424A1Engineered natural ligand-based car: directed evolution of the stress-receptor nkp30DARTMOUTH COLLEGE·Filed 2023·Application pending·0 cites
- 4761US10336804B2Chimeric NK receptor and methods for treating cancerDARTMOUTH COLLEGE·Filed 2015·Granted Jul 2, 2019·0 cites·19 claims
- 4860US12492376B2T-cell receptor-deficient T cell compositionsDARTMOUTH COLLEGE·Filed 2021·Granted Dec 9, 2025·0 cites·16 claims
- 4960US2022348872A1Chimeric antigen receptor anti-inflammatory cells and methods of useDARTMOUTH COLLEGE·Filed 2022·Application pending·0 cites
- 5059US2020157173A1Chimeric antigen receptor, regulatory cells and methods of useDARTMOUTH COLLEGE·Filed 2019·Application pending·0 cites
Showing the top 50 of 56 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Charles L. Sentman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →